You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lintuzumab

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

Acute Myeloid Leukemia, Relapsed Adult AML Trial in United States (Lintuzumab-Ac225, Venetoclax, Spironolactone)

Recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • Los Angeles, California
  • +4 more
Feb 22, 2022

Refractory Multiple Myeloma Trial in United States (Lintuzumab AC 225)

Terminated
  • Refractory Multiple Myeloma
  • Lintuzumab AC 225
  • Los Angeles, California
  • +4 more
Feb 22, 2022

AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

Completed
  • AML
  • Cytarabine (Phase 1 only)
  • +3 more
  • Los Angeles, California
  • +16 more
Feb 22, 2022

Acute Myeloid Leukemia Trial (Ac-Lintuzumab)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 6, 2019

Leukemia, MDS Trial in Columbus (lintuzumab, 5-azacytidine)

Terminated
Has Results
  • Leukemia
  • Myelodysplastic Syndromes
  • Columbus, Ohio
    Ohio State University Medical Center
Apr 3, 2017

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders Trial in United States (lintuzumab)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • lintuzumab
  • Denver, Colorado
  • +8 more
Dec 17, 2014

Acute Myeloid Leukemia Trial in United States (Lintuzumab (SGN-33), Low dose cytarabine, Placebo)

Completed
  • Acute Myeloid Leukemia
  • Lintuzumab (SGN-33)
  • +2 more
  • Mobile, Alabama
  • +19 more
Dec 17, 2014

Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in New York (biological, drug, radiation)

Completed
Has Results
  • Leukemia
  • +2 more
  • filgrastim
  • +2 more
  • New York, New York
    Memorial Sloan - Kettering Cancer Center
Dec 17, 2015

Leukemia Trial in Los Angeles (lintuzumab)

Unknown status
  • Leukemia
  • lintuzumab
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013

Leukemia Trial in New York (lintuzumab, cytarabine, idarubicin)

Completed
  • Leukemia
  • lintuzumab
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 20, 2013

Leukemia, MDS, Neutropenia Trial in New York (filgrastim, lintuzumab, cytarabine)

Completed
  • Leukemia
  • +2 more
  • filgrastim
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 1, 2013

Leukemia, MDS Trial in New York (lintuzumab)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • lintuzumab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 24, 2013

Leukemia Trial in Worldwide (lintuzumab, cytarabine, etoposide)

Unknown status
  • Leukemia
  • lintuzumab
  • +3 more
  • Los Angeles, California
  • +58 more
Nov 5, 2013

Leukemia Trial in New York (filgrastim, lintuzumab, arsenic trioxide)

Completed
  • Leukemia
  • filgrastim
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 15, 2013

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Disorders Trial in Houston (Hum-195/rGel)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Apr 1, 2013

MDS Trial in Worldwide (lintuzumab)

Withdrawn
  • Myelodysplastic Syndromes
  • lintuzumab
  • Innsbruck, Austria
  • +26 more
Jul 10, 2012

Myelodysplastic Syndrome (MDS) Trial in United States (lintuzumab, lenalidomide)

Completed
  • Myelodysplastic Syndrome (MDS)
  • Birmingham, Alabama
  • +7 more
Oct 7, 2011